Fate Therapeutics Inc (FATE)
4.135
+0.04
(+1.10%)
USD |
NASDAQ |
May 02, 14:50
Fate Therapeutics Price: 4.135 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 3.95 | 4.33 | 3.88 | 4.09 | 4.322M |
Apr 30, 2024 | 3.97 | 4.13 | 3.91 | 3.95 | 3.932M |
Apr 29, 2024 | 3.79 | 4.185 | 3.79 | 4.04 | 3.311M |
Apr 26, 2024 | 3.88 | 3.95 | 3.74 | 3.80 | 2.732M |
Apr 25, 2024 | 4.14 | 4.15 | 3.78 | 3.87 | 3.602M |
Apr 24, 2024 | 4.59 | 4.66 | 4.17 | 4.30 | 2.273M |
Apr 23, 2024 | 4.79 | 5.02 | 4.485 | 4.54 | 4.022M |
Apr 22, 2024 | 4.84 | 4.92 | 4.665 | 4.78 | 1.434M |
Apr 19, 2024 | 4.95 | 5.11 | 4.695 | 4.79 | 2.692M |
Apr 18, 2024 | 5.27 | 5.345 | 4.98 | 5.04 | 2.343M |
Apr 17, 2024 | 5.50 | 5.63 | 5.21 | 5.27 | 2.149M |
Apr 16, 2024 | 5.53 | 5.74 | 5.32 | 5.38 | 2.815M |
Apr 15, 2024 | 5.80 | 5.955 | 5.39 | 5.64 | 2.687M |
Apr 12, 2024 | 5.95 | 5.95 | 5.67 | 5.77 | 1.838M |
Apr 11, 2024 | 6.33 | 6.37 | 5.90 | 5.95 | 1.866M |
Apr 10, 2024 | 6.38 | 6.48 | 6.23 | 6.27 | 2.401M |
Apr 09, 2024 | 6.69 | 6.81 | 6.54 | 6.76 | 1.625M |
Apr 08, 2024 | 6.98 | 6.98 | 6.42 | 6.71 | 2.134M |
Apr 05, 2024 | 6.90 | 7.14 | 6.803 | 6.92 | 1.183M |
Apr 04, 2024 | 7.18 | 7.345 | 6.925 | 6.97 | 1.202M |
Apr 03, 2024 | 6.78 | 7.29 | 6.65 | 7.01 | 2.643M |
Apr 02, 2024 | 6.84 | 7.08 | 6.75 | 6.80 | 1.873M |
Apr 01, 2024 | 7.33 | 7.33 | 6.89 | 7.08 | 1.856M |
Mar 28, 2024 | 7.27 | 7.65 | 7.23 | 7.34 | 2.716M |
Mar 27, 2024 | 6.97 | 7.37 | 6.77 | 7.34 | 2.111M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.65
Minimum
Oct 27 2023
117.40
Maximum
Jan 14 2021
32.50
Average
24.17
Median
Price Benchmarks
Amicus Therapeutics Inc | 10.42 |
Regeneron Pharmaceuticals Inc | 937.48 |
Sarepta Therapeutics Inc | 131.96 |
ADMA Biologics Inc | 6.69 |
Ocular Therapeutix Inc | 5.755 |
Price Related Metrics
PS Ratio | 6.405 |
Price to Book Value | 1.114 |
Earnings Yield | -39.66% |
Market Cap | 410.35M |